Omega-3 oil and bone health
Plant-based omega-3 fatty acid supplementation, acceptability and efficacy for bone health
The Royal Australian College of General Practitioners (RACGP)
40 participants
Dec 1, 2008
Interventional
Conditions
Summary
Omega-3 oils are known to have benefits for joints, skin and the circulation. There are reasons to believe that they may help improve bone health in people with low bone density. This study aims to examine the safety, effectiveness and acceptability of an omega-3 oil, docosohexanoic acid (DHA) when given for 1 year in combination with calcium and vitamin D.
Eligibility
Inclusion Criteria2
- DEXA BMD T-score between -1.0 and -2.4 (inclusive)
- abbreviations as noted above: Bone Mineral density (BMD); Dual Energy X-ray Absorptiometry (DEXA)
Exclusion Criteria1
- already on antiresorptive agents
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1 year of oral docosohexanoic acid (DHA) 400 mg daily. DHA is of algal origin (i.e. suitable for vegetarians/vegans). All participants will receive oral vitamin D3 1000 IU daily with calcium carbonate 1200 mg daily
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000238279